A review of the effects of the oral direct thrombin inhibitor ximelagatran on coagulation assays
Thromb Res
.
2005;115(1-2):9-18.
doi: 10.1016/j.thromres.2004.07.001.
Authors
Stefan C Carlsson
1
,
Christer Mattsson
,
Ulf G Eriksson
,
Troy C Sarich
,
Karin Wåhlander
,
Asa Eliasson
,
Björn W Karlson
,
Sunita B Sheth
,
Peter Held
Affiliation
1
AstraZeneca R&D Mölndal, Mölndal, Sweden.
[email protected]
PMID:
15567447
DOI:
10.1016/j.thromres.2004.07.001
No abstract available
Publication types
Review
MeSH terms
Azetidines / pharmacology*
Benzylamines
Blood Coagulation / drug effects*
Blood Coagulation Tests*
Dose-Response Relationship, Drug
Humans
Inhibitory Concentration 50
Substances
Azetidines
Benzylamines
ximelagatran